Drug trials : India’s crisis of confidence

Reuters reports that in the last decade fewer children are dying of leukemia most likely due to advances in new drug combinations. However, infants are still getting a more aggressive form of the disease as a result of which survival rates are lower than those for young children and adolescents. In spite of the strides …

Advertisement

India’s compulsory licence to Natco : follow-up thoughts

In granting a compulsory licence to Natco on Bayer's cancer drug Nexavar the patents office has done its job well. It has put a provision in the law meant expressly to balance public good with incentives for innovation to its right use. See Shamnad Basheer's lucid analysis of the order on spicyip. But it is …

India’s compulsory licence to Natco : First cut

I quickly read through the Indian Patent Office's order granting a compulsory licence to Hyderabad's Natco to make and sell its generic of Bayer's patented liver and kidney cancer drug Nexavar in India.  While I'm no legal expert and I've just speed-read the order, some things just stand out so here goes. The order as …

Less is more for LSD sufferers on Rare Disease Day

What would you do if your child were struck by a strange illness and began to wilt before your eyes. An illness that few doctors understood, even fewer could treat, that most likely did not have a cure, and even if it did,  you couldn't afford it? Faced by a parent's worse nightmare come true …